1. Home
  2. SEAT vs TCRX Comparison

SEAT vs TCRX Comparison

Compare SEAT & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivid Seats Inc.

SEAT

Vivid Seats Inc.

HOLD

Current Price

$5.88

Market Cap

66.0M

Sector

Industrials

ML Signal

HOLD

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

HOLD

Current Price

$1.06

Market Cap

57.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEAT
TCRX
Founded
2001
2018
Country
United States
United States
Employees
768
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.0M
57.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SEAT
TCRX
Price
$5.88
$1.06
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
$32.94
$8.50
AVG Volume (30 Days)
131.6K
455.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.18
EPS
N/A
N/A
Revenue
N/A
$2,816,000.00
Revenue This Year
N/A
$286.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.42
$0.88
52 Week High
$35.00
$2.57

Technical Indicators

Market Signals
Indicator
SEAT
TCRX
Relative Strength Index (RSI) 40.52 52.25
Support Level $1.52 $0.90
Resistance Level $7.84 $1.23
Average True Range (ATR) 0.68 0.07
MACD -0.13 0.01
Stochastic Oscillator 17.67 65.15

Price Performance

Historical Comparison
SEAT
TCRX

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Share on Social Networks: